News items
February 7, 2012
Metactive Medical, LLC is pleased to announce that its President, Xandra M. Sifuentes, has been chosen as a 2012 PIPELINE Innovator in the first Regional Class of PIPELINE entrepreneurs.
November 29, 2011
Novita also announced the hiring of Xandra Sifuentes, M.B.A. as President of Metactive. "Xandra's engineering background and experience in leading medical device start-ups are ideal to lead the spinout of Metactive," said Novita's Nicholas Franano, M.D., President and CEO of Novita.
September 15, 2011
Novita Therapeutics, LLC (Novita) announced today that the Kansas Bioscience Authority (KBA) has made a $600,000 equity investment in Novita.
May 31, 2011
Novita Therapeutics, LLC ("Novita") announced today it has raised $3 million in a new financing from Open Prairie Ventures ("Open Prairie"), increasing the total capital raised to date to $5 million.
July 1, 2010
Novita Therapeutics ("Novita") announced today the closing of a follow-on round of angel financing, bringing the total cash investment to $930,000 since the company's founding in November 2009.
In related news, Novita also announced the signing of an agreement with Cirtec Medical, Inc., for the design of a novel, implantable cardiovascular device. The device is intended to treat a chronic condition impacting more than 200,000 patients in the U.S., and will provide a new treatment option that will reduce morbidity and mortality for these patients, while also reducing the overall cost of their care.
June 10, 2010
Novita Therapeutics ("Novita") announced today that the Kansas Bioscience Authority ("KBA") has awarded Novita a $72,578 grant to complete design work on an implantable cardiovascular device under development at Novita.
January 16, 2010
Two local biotech entrepreneurs plan to use a cutting-edge business approach to replicate their previous success.
Novita Therapeutics LLC is a new venture by Dr. Nicholas Franano and his father-in-law, William Whitaker. The company will look to develop drugs and medical devices to treat cardiovascular, renal and gastrointestinal diseases, in keeping with Franano's training as an interventional radiologist.
The two were the founders of Proteon Therapeutics Inc., which is developing...
January 15, 2010
Lenexa, KS, January 15, 2010 - Nicholas Franano, M.D. and William P. Whitaker, Esq., the founders of Proteon Therapeutics, Inc. ("Proteon") announced today that they have launched Novita Therapeutics, LLC ("Novita"), a new biopharmaceutical and medical device firm located in Lenexa, KS.